Error: Could not add to watchlist. X
+ Watchlist

Opthea Ltd

CKDXF:US
OTC US
Price not available for CKDXF:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
-
Market Cap (m USD)
113.902
Shares Outstanding (m)
200.574
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.17%
% Price Change
-0.55%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Opthea Limited is a biologics drug developer for ophthalmic diseases. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.
Address
Suite 0403, Level 4
650 Chapel Street
South Yarra, VIC 3141
Australia
Phone
61-3-9826-0399
Show More